Key facts
- This page summarizes Agoglia Hoeltzel Mary T.'s Form 4 filing for Cigna Group (CI).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 May 2024, 17:22.
Agoglia Hoeltzel Mary T. - 14 May 2024 Form 4 Insider Report for Cigna Group (CI)
- Reporting relationship
- SVP Tax & Chief Acct. Officer
- Issuer ticker
- CI
- Reported as of
- 14 May 2024
- Net transaction value
- -$1,354,608
- SEC form
- 4
- Accepted by SEC
- 16 May 2024, 17:22:41 UTC
- Prior SEC filing
- 05 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- Matthew Arnold, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Agoglia Hoeltzel Mary T. filed Form 4 for Cigna Group (CI) on 16 May 2024.
Change
- Previous filing in this sequence was filed on 05 Mar 2024.
- Current net transaction value: -$1,354,608.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CI
transaction
Common Stock, $.01 Par Value
Options Exercise
- Transaction value
- $718,842
- Shares
- +5,946
- Change %
- +229%
- Price
- $120.90
- Shares after
- 8,541
- Date
- 14 May 2024
- Ownership
- Direct
- Footnotes
- F1
CI
transaction
Common Stock, $.01 Par Value
Sale
- Transaction value
- $2,073,449
- Shares
- -5,946
- Change %
- -70%
- Price
- $348.71
- Shares after
- 2,595
- Date
- 14 May 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CI
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,946
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 14 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock, $.01 Par Value
- Underlying amount
- 5,946
- Exercise price
- $120.90
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Balance includes 8.414 shares of common stock received from her participation in a dividend reinvestment plan.
Footnote F2
Represents the weighted average price of the shares sold. The prices actually received ranged from $348.68 to $349.01 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Footnote F3
This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.